USFDA completes inspection at Unichem Lab’s Kolhapur facility

20 Sep 2019 Evaluate

The United States Food and Drug Administration (USFDA) has successfully concluded inspection at Unichem Laboratories’ newly commissioned Active Pharmaceutical Ingredients (APIs) facility at Kolhapur in Maharashtra without any FDA form 483 issued.

The inspection was conducted from September 16, 2019 to September 20, 2019. The inspection was a cGMP surveillance and pre-approval inspection.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

724.60 16.50 (2.33%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.